Constitutive nuclear translocation of NF-κB in B cells in the absence of IκB degradation

Journal of Immunology

Volumn 163, Issue 1, 1999, Pages 269-277

  Doerre, Stefan ^a   Corley, Ronald B ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CYCLOHEXIMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISOPROTEIN; LIPOPOLYSACCHARIDE; LYMPHOCYTE RECEPTOR; PROTEIN I KAPPA B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; LYMPHOCYTE SUBPOPULATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REGULATORY MECHANISM;

ANIMALS; B-LYMPHOCYTE SUBSETS; BIOLOGICAL TRANSPORT; CELL NUCLEUS; DNA-BINDING PROTEINS; I-KAPPA B PROTEINS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDES; LYMPHOMA, B-CELL; MICE; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0033169043     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Grilli, M., J. J. S. Chiu, and M. J. Lenardo. 1993. NF-κB and ReI: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1.
2. Liou, H.-C., and D. Baltimore. 1993. Regulation of the NF-κB/Rel transcription factor and IκB inhibitor system. Curr. Opin. Cell Biol. 5:477.
3. Kopp, E. B., and S. Ghosh. 1995. NF-κ B and Rel proteins in innate immunity. Adv. Immunol. 58:1.
4. Sha, W. C. 1998. Regulation of immune responses by NF-κB/Rel transcription factors. J. Exp. Med. 187:143.
5. Sen, R., and D. Baltimore. 1986. Inducibility of K immunoglobulin enhancer binding protein NF-κB by a posttranslational mechanism. Cell 47:921.
6. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705.
7. Scherer, D. C., J. A. Brockman, H. H. Bendall, G. M. Zhang, D. W. Ballard, and E. M. Oltz. 1996. Corepression of ReIA and c-Rel inhibits immunoglobulin κ gene transcription and rearrangement in precursor B lymphocytes. Immunity 5:563.
8. Lee, H., M. Arsura, M. Wu, M. Duyao, A. J. Buckler, and G. E. Sonenshein. 1995. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J. Exp. Med. 181: 1169.
9. Schauer, S. L., Z. Wang, G. E. Sonenshein, and T. L. Rothstein. 1996. Maintenance of nuclear factor-κB/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of IκB proteins. J. Immunol. 157:81.
10. Grumont, R. J., I. J. Rourke, L. A. O'Reilly, A. Strasser, K. Miyake, W. Sha, and S. Gerondakis. 1998. B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187:663.
11. Iciek, L. A., S. A. Delphin, and J. Stavnezer. 1997. CD40 cross-linking induces Igε germline transcripts in B cells via activation of NF-κB: synergy with IL-4 induction. J. Immunol. 158:4769.
12. Lin, S. C., and J. Stavnezer. 1996. Activation of NF-κB/Rel by CD40 engagement induces the mouse germ line immunoglobulin Cγ1 promoter. Mol. Cell. Biol. 16:4591.
13. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
14. Baeuerle, P. A., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540.
15. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405.
16. Miyamoto, S., and I. M. Verma. 1995. Rel/NF-κB/IκB story. Adv. Cancer Res. 66:255.
17. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
18. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573.
19. Simeonidis, S., S. Liang, G. Chen, and D. Thanos. 1997. Cloning and functional characterization of mouse IκBε. Proc. Natl. Acad. Sci. USA 94:14372.
20. Whiteside, S. T., J.-C. Epinat, N. R. Rice, and A. Israel. 1997. IκBε, a novel member of the IκB family, controls ReIA and cRel NF-κB activity. EMBO J. 16:1413.
21. Stancovski, I., and D. Baltimore. 1997. NF-κB activation: the IκB kinase revealed? Cell 91:299.
22. May, M. J., and S. Ghosh. 1998. Signal transduction through NF-κB. Immunol. Today 19:80.
23. Baeuerle, P. A., and D. Baltimore. 1996. NF-κB: ten years after. Cell 87:13.
24. Kistler, B., A. Rolink, R. Marienfeld, M. Neumann, and T. Wirth. 1998. Induction of nuclear factor-κB during primary B cell differentiation. J. Immunol. 160: 2308.
25. Miyamoto, S., M. J. Schmitt, and I. M. Verma. 1994. Qualitative changes in the subunit composition of κB-binding complexes during murine B-cell differentiation. Proc. Natl. Acad. Sci. USA 91:5056.
26. Grumont, R. J., I. B. Richardson, C. Gaff, and S. Gerondakis. 1993. Rel/NF-κB nuclear complexes that bind κB sites in the murine c-Rel promoter are required for constitutive c-Rel transcription in B-cells. Cell Growth Difer. 4:731.
27. Francis, D. A., J. G. Karras, X.-y. Ke, R. Sen, and T. L. Rothstein. 1995. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 7:151.
28. Francis, D. A., R. Sen, N. Rice, and T. L. Rothstein. 1998. Receptor-specific induction of NF-κB components in primary B cells. Int. Immunol. 10:285.
29. Neumann, M., G. Wohlleben, S. Chuvpilo, B. Kistler, T. Wirth, E. Serfling, and A. Schimpl. 1996. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to persistent nuclear accumulation of RelB. J. Immunol. 157:4862.
30. Rice, N. R., and M. K. Ernst. 1993. In vivo control of NF-κB activation by IκBα. EMBO J. 12:4685.
31. Liou, H.-C., W. C. Sha, M. L. Scott, and D. Baltimore. 1994. Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 14:5349.
32. Miyamoto, S., P. J. Chiao, and I. M. Verma. 1994. Enhanced IκBαr degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines. Mol. Cell. Biol. 14:3276.
33. Schauer, S. L., R. E. Bellas, and G. E. Sonenshein. 1998. Dominant signals leading to inhibitor κB protein degradation mediate CD40 ligand rescue of WEHI231 immature B cells from receptor-mediated apoptosis. J. Immunol. 160: 4398.
34. King, L. B., F. E. Lund, D. A. White, S. Sharma, and R. B. Corley. 1990. Molecular events in B lymphocyte differentiation: inducible expression of the endogenous mouse mammary tumor proviral gene, Mtv-9. J. Immunol. 144:3218.
35. Lund, F. E., and R. B. Corley. 1991. Regulated expression of mouse mammary tumor proviral genes in cells of the B lineage. J. Exp. Med. 174:1439.
36. Bomemann, K. D., J. W. Brewer, E. Perez, S. Doerre, R. Sitia, and R. B. Corley. 1997. Secretion of soluble pre-B cell receptors by pre-B cells. J. Immunol. 158: 2511.
37. blk kinase in signaling growth arrest and apoptosis. Immunol. Rev. 132:163.
38. + normal B cells. Immunol. Rev. 93:35.
39. King, L. B., and R. B. Corley. 1989. Characterization of a pre-secretory phase in B cell differentiation. Proc. Natl. Acad. Sci. USA 86:2814.
40. Glimcher, L. H., D. J. McKean, E Choi, and J. G. Seidman. 1985. Complex regulation of class II gene expression: analysis with class II mutant cell lines. J. Immunol. 135:3542.
41. + B cell hybridomas to H-2-restricted T cell hybridomas. Proc. Natl. Acad. Sci. USA 79:3604.
42. + B cell lymphoma, CH12, expressing isotypes other than IgM. J. Immunol. 140:4355.
43. White, J., M. Blackman, J. Bill, J. Kappler, P. Marrack, D. P. Gold, and W. Born. 1989. Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143:1822.
44. + B cell lymphoma. J. Immunol. 138:3075.
45. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
46. Ballard, D. W., W. H. Walker, S. Doerre, P. Sista, J. A. Molitor, E. P. Dixon, N. J. Peffer, M. Hannink, and W. C. Greene 1990. The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function. Cell 63:803.
47. Molitor, J. A., W. H. Walker, S. Doerre, D. W. Ballard, and W. C. Greene. 1990. NF-κB: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc. Natl. Acad. Sci. USA 87:10028.
48. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711.
49. Bohnlein, E., J. W. Lowenthal, M. Siekevitz, D. W. Ballard, B. R. Franza, and W. C. Greene. 1988. The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-α gene and type 1 HIV. Cell 53:827.
50. Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA 86:2336.
51. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature 365:182.
52. Beg, A. A., T. S. Finco, P. Vv. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:3301.
53. Baeuerle, P. A., and D. Baltimore. 1989. A 65-kD subunit of active NF-κB is required for inhibition of NF-κB by IκB. Genes Dev. 3:1689.
54. Dobrzanski, P., R. P. Ryseck, and R. Bravo. 1994. Differential interactions of Rel-NF-κB complexes with IκBα determine pools of constitutive and inducible NF-κB activity. EMBO J. 13:4608.
55. Phillips, R. J., and S. Ghosh. 1997. Regulation of IκBβ in WEHI 231 mature B cells. Mol. Cell. Biol. 17:4390.
56. Miyamoto, S., B. J. Seufzer, and S. D. Shumway. 1998. Novel IκBα proteolytic pathway in WEHI231 immature B cells Mol. Cell. Biol. 18:19.
57. Imbert, V., R. A. Rupec, A. Livolsi, H. L. Pahl, E. B. M. Traenckner, C. Mueller-Dieckmann, D. Farahifar, B. Rossi, P. Auberger, P. A. Baeuerle, et al. 1996. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell 86:787.
58. May, M. J., and S. Ghosh. 1997. Rel/NF-κB and IκB proteins: an overview. Semin. Cancer Biol. 8:63.
59. Sun, S. C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259:1912.
60. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc. Natl. Acad. Sci. USA 90:2532.
61. Scott, M. L., T. Fujita, H. C. Liou, G. P. Nolan, and D. Baltimore. 1993. The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes Dev. 7:1266.
62. Lam, K. P., R. Kuhn, and K. Rajewsky. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 19:1073.
63. Sonenshein, G. E. 1997. Rel/NF-κB transcription factors and the control of apoptosis. Semin. Cancer Biol. 8:113.